Abstract
High-mobility group box-1 (HMGB1) is a pro-inflammatory cytokine that may contribute to the pathogenesis of micro- and macrovascular complications commonly observed in diabetes. We investigated whether HMGB1 is associated with: i) markers of low-grade inflammation (LGI) and endothelial dysfunction (ED) and pulse pressure (PP, a marker of arterial stiffness); ii) prevalent nephropathy, retinopathy and cardiovascular disease (CVD) in type 1 diabetes; and iii) the potential mediating roles of LGI, ED and PP therein.
| Lingua originale | Inglese |
|---|---|
| pagine (da-a) | 325-332 |
| Numero di pagine | 8 |
| Rivista | European Journal of Endocrinology |
| Volume | 166 |
| Numero di pubblicazione | 2 |
| DOI | |
| Stato di pubblicazione | Pubblicato - 2012 |
OSS delle Nazioni Unite
Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile
-
SDG 3 Salute e benessere
All Science Journal Classification (ASJC) codes
- Endocrinologia, Diabete e Metabolismo
- Endocrinologia
Keywords
- Adult
- Albuminuria
- Biological Markers
- Cardiovascular Diseases
- Case-Control Studies
- Cross-Sectional Studies
- Diabetes Complications
- Diabetes Mellitus
- Europe
- Female
- Glomerular Filtration Rate
- HMGB1 Protein
- Humans
- Male
- Middle Aged
- Risk Factors
- Severity of Illness Index
- Type 1
Fingerprint
Entra nei temi di ricerca di 'Serum high-mobility group box-1 levels are positively associated with micro- and macroalbuminuria but not with cardiovascular disease in type 1 diabetes: the EURODIAB Prospective Complications Study'. Insieme formano una fingerprint unica.Cita questo
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver